Literature DB >> 8193642

Expression of human lactoferrin in milk of transgenic mice.

G J Platenburg1, E P Kootwijk, P M Kooiman, S L Woloshuk, J H Nuijens, P J Krimpenfort, F R Pieper, H A de Boer, R Strijker.   

Abstract

The expression of human lactoferrin (hLF) in the milk of transgenic mice is described. Regulatory sequences derived from the bovine alpha S1-casein gene were fused to the coding sequence of the hLF cDNA and several lines of transgenic mice were generated. Human LF RNA was detected exclusively in the mammary gland of lactating females and only after the onset of lactation. No aberrant RNA products could be detected using northern blotting and primer extension analysis. The hLF concentrations in the milk ranged from less than 0.1 to 36 micrograms ml-1. Human LF thus expressed did not differ from human milk derived LF, with respect to molecular mass and immunoreactivity with monoclonal and polyclonal antibodies.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8193642     DOI: 10.1007/bf01974087

Source DB:  PubMed          Journal:  Transgenic Res        ISSN: 0962-8819            Impact factor:   2.788


  37 in total

Review 1.  Biomolecule-cell interactions and the regulation of myelopoiesis.

Authors:  H E Broxmeyer
Journal:  Int J Cell Cloning       Date:  1986-11

2.  Nucleotide sequence of human lactoferrin cDNA.

Authors:  M J Powell; J E Ogden
Journal:  Nucleic Acids Res       Date:  1990-07-11       Impact factor: 16.971

3.  Nucleotide sequences of bovine alpha S1- and kappa-casein cDNAs.

Authors:  A F Stewart; I M Willis; A G Mackinlay
Journal:  Nucleic Acids Res       Date:  1984-05-11       Impact factor: 16.971

4.  Modulation of classical C3 convertase of complement by tear lactoferrin.

Authors:  A Kijlstra; S H Jeurissen
Journal:  Immunology       Date:  1982-10       Impact factor: 7.397

5.  Proteolytic inactivation of plasma C1- inhibitor in sepsis.

Authors:  J H Nuijens; A J Eerenberg-Belmer; C C Huijbregts; W O Schreuder; R J Felt-Bersma; J J Abbink; L G Thijs; C E Hack
Journal:  J Clin Invest       Date:  1989-08       Impact factor: 14.808

6.  Production of biologically active recombinant human lactoferrin in Aspergillus oryzae.

Authors:  P P Ward; J Y Lo; M Duke; G S May; D R Headon; O M Conneely
Journal:  Biotechnology (N Y)       Date:  1992-07

7.  Generation of transgenic dairy cattle using 'in vitro' embryo production.

Authors:  P Krimpenfort; A Rademakers; W Eyestone; A van der Schans; S van den Broek; P Kooiman; E Kootwijk; G Platenburg; F Pieper; R Strijker
Journal:  Biotechnology (N Y)       Date:  1991-09

8.  Transgenic production of a variant of human tissue-type plasminogen activator in goat milk: generation of transgenic goats and analysis of expression.

Authors:  K M Ebert; J P Selgrath; P DiTullio; J Denman; T E Smith; M A Memon; J E Schindler; G M Monastersky; J A Vitale; K Gordon
Journal:  Biotechnology (N Y)       Date:  1991-09

9.  Plasma elastase alpha 1-antitrypsin and lactoferrin in sepsis: evidence for neutrophils as mediators in fatal sepsis.

Authors:  J H Nuijens; J J Abbink; Y T Wachtfogel; R W Colman; A J Eerenberg; D Dors; A J Kamp; R J Strack van Schijndel; L G Thijs; C E Hack
Journal:  J Lab Clin Med       Date:  1992-02

10.  Kinetic effect of human lactoferrin on the growth of Escherichia coli 0111.

Authors:  J Stuart; S Norrell; J P Harrington
Journal:  Int J Biochem       Date:  1984
View more
  27 in total

Review 1.  Structure and biological actions of lactoferrin.

Authors:  J H Nuijens; P H van Berkel; F L Schanbacher
Journal:  J Mammary Gland Biol Neoplasia       Date:  1996-07       Impact factor: 2.673

Review 2.  Mammary gland immunity and mastitis susceptibility.

Authors:  Lorraine M Sordillo; Katie L Streicher
Journal:  J Mammary Gland Biol Neoplasia       Date:  2002-04       Impact factor: 2.673

3.  A 3,387 bp 5'-flanking sequence of the goat alpha-S1-casein gene provides correct tissue-specific expression of human granulocyte colony-stimulating factor (hG-CSF) in the mammary gland of transgenic mice.

Authors:  Irina A Serova; Gennady A Dvoryanchikov; Ludmila E Andreeva; Ivan A Burkov; Luciene P B Dias; Nariman R Battulin; Alexander V Smirnov; Oleg L Serov
Journal:  Transgenic Res       Date:  2011-09-01       Impact factor: 2.788

4.  High-level expression of bovine alpha s1-casein in milk of transgenic mice.

Authors:  M Rijnkels; P M Kooiman; G J Platenburg; M van Dixhoorn; J H Nuijens; H A de Boer; F R Pieper
Journal:  Transgenic Res       Date:  1998-01       Impact factor: 2.788

5.  Bovine alpha s1-casein gene sequences direct high level expression of human granulocyte-macrophage colony-stimulating factor in the milk of transgenic mice.

Authors:  M Uusi-Oukari; J M Hyttinen; V P Korhonen; A Västi; L Alhonen; O A Jänne; J Jänne
Journal:  Transgenic Res       Date:  1997-01       Impact factor: 2.788

6.  Organization of the bovine casein gene locus.

Authors:  M Rijnkels; P M Kooiman; H A de Boer; F R Pieper
Journal:  Mamm Genome       Date:  1997-02       Impact factor: 2.957

7.  Expression of full-length bioactive antimicrobial human lactoferrin in potato plants.

Authors:  D K Chong; W H Langridge
Journal:  Transgenic Res       Date:  2000-02       Impact factor: 2.788

8.  Heterogeneity in utilization of N-glycosylation sites Asn624 and Asn138 in human lactoferrin: a study with glycosylation-site mutants.

Authors:  P H van Berkel; H A van Veen; M E Geerts; H A de Boer; J H Nuijens
Journal:  Biochem J       Date:  1996-10-01       Impact factor: 3.857

9.  Could protein tertiary structure influence mammary transgene expression more than tissue specific codon usage?

Authors:  Zuyong He; Yiqiang Zhao; Gui Mei; Ning Li; Yaosheng Chen
Journal:  Transgenic Res       Date:  2010-06-19       Impact factor: 2.788

10.  Mammary gland-specific hypomethylation of Hpa II sites flanking the bovine alpha S1-casein gene.

Authors:  G J Platenburg; E J Vollebregt; C N Karatzas; E P Kootwijk; H A De Boer; R Strijker
Journal:  Transgenic Res       Date:  1996-11       Impact factor: 2.788

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.